Table 3.
Proportion of subjects with AKI based on clinical adjudication (CAC) versus the KDIGO AKI consensus criteria
| KDIGO |
||||
|---|---|---|---|---|
| (−) | (+) | Total | Agreement | |
| CAC | ||||
| No AKI (1/3 or 0/3) | 330 (80.9%) | 7 (1.7%) | 337 (82.6%) | 97.9% |
| AKI (2/3 or 3/3) | 6 (1.5%) | 65 (15.9%) | 71 (17.4%) | 91.5% |
| Total | 336 (82.4%) | 72 (17.6%) | 408 (100%) | 96.8% |
For the purposes of this study, those with KDIGO Stage 1 AKI were not considered to have AKI. Agreement was present if the clinical adjudication committee adjudicated that AKI was not present and the maximum KDIGO stage was 0 or 1 or if the clinical adjudication committee adjudicated that AKI was present and the maximum KDIGO stage was 2 or 3.